Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21200591rdf:typepubmed:Citationlld:pubmed
pubmed-article:21200591lifeskim:mentionsumls-concept:C0009968lld:lifeskim
pubmed-article:21200591pubmed:issuePt 1lld:pubmed
pubmed-article:21200591pubmed:dateCreated2011-1-4lld:pubmed
pubmed-article:21200591pubmed:abstractTextThe title compound, [Cu(C(7)H(3)NO(5))(C(12)H(8)N(2))(H(2)O)]·4.5H(2)O or [Cu(hypydc)(phen)(H(2)O)]·4.5H(2)O (phen is 1,10-phenanthroline and hypydcH(2) is 4-hydroxy-pyridine-2,6-dicarboxylic acid), was obtained by the reaction of copper(II) nitrate hexa-hydrate with the proton-transfer compound (phenH)(2)(hypydc) in aqueous solution. Both the cationic and the anionic fragments of the proton-transfer compound are involved in complexation. Each Cu(II) atom has a distorted octa-hedral geometry. It is hexa-coordinated by three O atoms and three N atoms, from one phen fragment (as bidentate ligand), one (hypydc)(2-) unit (as tridentate ligand) and a water mol-ecule. In the crystal structure, O-H?O and C-H?O hydrogen bonds, and ?-? stacking inter-actions [centroid-to-centroid distance 3.5642?(11)?Å] between the phen ring systems, contribute to the formation of a three-dimensional supra-molecular structure.lld:pubmed
pubmed-article:21200591pubmed:languageenglld:pubmed
pubmed-article:21200591pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21200591pubmed:statusPubMed-not-MEDLINElld:pubmed
pubmed-article:21200591pubmed:issn1600-5368lld:pubmed
pubmed-article:21200591pubmed:authorpubmed-author:AghabozorgHos...lld:pubmed
pubmed-article:21200591pubmed:authorpubmed-author:Soleimannejad...lld:pubmed
pubmed-article:21200591pubmed:authorpubmed-author:Attar...lld:pubmed
pubmed-article:21200591pubmed:authorpubmed-author:MotyeianElham...lld:pubmed
pubmed-article:21200591pubmed:authorpubmed-author:GhadermaziMoh...lld:pubmed
pubmed-article:21200591pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21200591pubmed:volume64lld:pubmed
pubmed-article:21200591pubmed:ownerNLMlld:pubmed
pubmed-article:21200591pubmed:authorsCompleteYlld:pubmed
pubmed-article:21200591pubmed:paginationm252-3lld:pubmed
pubmed-article:21200591pubmed:dateRevised2011-11-11lld:pubmed
pubmed-article:21200591pubmed:year2007lld:pubmed
pubmed-article:21200591pubmed:articleTitleAqua-(4-hydroxy-pyridine-2,6-dicarboxyl-ato)(1,10-phenanothroline)copper(II) 4.5-hydrate.lld:pubmed
pubmed-article:21200591pubmed:publicationTypeJournal Articlelld:pubmed